My belief is that there may be a delay in completing the audit due to coved restrictions. Hopefully as we return to a level of normalcy, approval can come within the next few weeks.

Is this the post you are referring to?

This is just soo heartbreaking. I just can't understand why this share price is at this level. I acknowledge Sonny may have his shortcomings as a CEO but I guess the greed of the market makers / savy traders will always WIN.

My average is already soo high ($15), YES that high and I wasn't able to invest in the offering. I guess the best way to average down is to sell on the next spike and just purchase lower.

This is just beyond ridiculous. I hope one day soon, loyal investors (over 3-years) can finally see the light.

In addition, given the proven connections between ZBH and Sintx, hopefully, this year, long term shareholders would have a reason to smile.

QUOTE:
The second thing I'd say, though, is beyond the priority to continue to delever the balance sheet, we are in a better position now operationally, financially, I think strategically as well, where if we see attractive M&A targets that meet our strategic filters, our financial filters, but also maintain a strong capital structure and profile and investment grade, we may decide to invest capital into M&A in 2020 and beyond. So again, organically, we expect to continue to delever the balance sheet.

But again, we may also decide to deploy some capital toward M&A that meets all of our structures that I talked about.

I considered $2.00 a gift when considering the huge potential of Sintx.
With the regular tweets, there is alot going on in the background but I just can't understand the absence of formal PR's. Other companies would have promoted / pumped news of lesser substance. This reduction in the strike price is another dagger for loyal shareholders who do not have the funds to invest further.

I just can't wrap my mind around the fact that you want shareholders to participate in the offering, but instead of giving positive news and raising the current market price (to make the offering more attractive), you take the easy route and price it at current levels. Makes me think, that any partnership is either delayed for whatever reason or there is no merger on the horizon.

Generating this quantum of funding at this time, makes me question whether Sonny prefers to maintain full control of the entity going forward as there may have been no need for this level of financing. I however remain hopeful that the sub rights are cancelled due to a strategic event as further extensions may result in further downward adjustments to the strike price.

Agreed that the potential markets are huge and based on what Hanson said, whatever deal that is under consideration at this time may be too much of a bite now....at this stage they could offer a 1 to 1 exchange of shares with future milestone payments and still the initial outlay would be less than 500 mil, using the implex sale as a base....I am sure current shareholders would willingly accept this...with no need for the offering..this would allow them sufficient time to explore these other opportunities...

With the offering, outstanding shares will more than likely triple and for the retail investor who cannot participate due to a lack of funds, the potential return would be substantially lower.

I am just living in hope that the RTM happens sooner rather than later whilst benefiting the loyal shareholders.

Even better would be a termination of the sub rights if some sort of partnership or m&a is announced...anybody who believes in this tech should have been invested already.

Was re-reading the key dates and pricing. My only concern is whether or not the warrants can be re-priced because a $2 exercise price for a 5-year period tells me that either the share price is not expected to be significantly higher or this is a mechanism to reward long-standing shareholders who have been through multiple RS and this allows for the acquisition of cheap shares.
I was just hoping the strike prices could have been substantially higher so as to limit the proposed dilution for the average retailer who may not have the funds to participate.

Do you see this as a mechanism to potentially reward long-standing shareholders of this company? Many retail holders have much higher averages and may not have the resources to be able to participate in this subscription rights..if I am correct, this will lead to a doubling of existing outstanding shares..for my part, I Hope long-standing shareholders can finally be rewarded handsomely and it does not take additional years.

Good sound bites from the conference call..agree with Boston as it seems that they prefer to pursue the route of partnership prior to finalizing any M&A transaction. The mitigant may however be the strong M&A team assembled. My view is that you don’t establish such a team if there was not any active targets.
While a partnership may result in upfront payments, the share price for Sintx may not be drastically impacted so as to benefit shareholders of 2016. For any company to see the benefit of a partnership leading to M&A, a period of 12-18 months is likely.
For our sake, I hope there is an immediate merger given the proven technology and I am quite happy accepting a small upfront payment with shares supplemented with future payouts based on milestones

Yes my mistake. I was in ATOS which did an RS previously. I tend to agree that something is being hidden for whatever reasons. Hopefully the "big picture" is revealed shortly.

I have been in this stock since August 2016 (and remained faithful), hence this will be my 3rd RS. I have tried to average down with limited resources but my average is still over $1. I have learnt alot along the way through the research provided by Boston, Ash and others. I am trying to remain upbeat as I believe that this gem will be acquired / merge in short order, however I can't help but feel disappointed with the minimal communication and what appears to be a disregard to loyal longstanding investors. In addition, I cannot wrap my mind around the recent equity raise. Minimal amount raised and potentially doubling outstanding shares.

An RS of 1:30 will literally wipe-out most of my shares with a required BE price of > $50. Given the time spent in this stock, I am really hoping to recover my funds as well as some profit given the reduced float. Hopefully no further dilution and we wait for management's next move.

https://www.sintx.com/news-media/press-releases/detail/134/sintx-technologies-announces-stockholders-approve-reverse

I re-read the transcript and yes it was totally avoided. We can infer that this is good or bad...good that he does not want to "hint" to his competitors or bad that things are off the table temporarily.

While I don't have an issue with the RS (if required), my issue is with the potential dilution (if required) in an effort to raise further operating capital. For our sake, let's hope that some commercialization deals are signed quickly or failing which an M&A as Hanson highlighted may be possible in the second half of 2019.

Thanks

Is the Japan Clearance no longer on the table? Haven't heard anything on this front for a while.

Does anyone notice that the last buy before close of day is usually a relatively substantial buy at the high / close to the high for the day? Can we read anything into this?

Thank you. I made a decision to invest in this stock based on all the views and information shared both negative and positive. At times, I have become despondent but I honestly believe that Zimmer will acquire or merge with Sintx. The IP remains the crown jewel and hopefully we will get fair value for our investment in the future.

The majority of longs are down considerably, but like Implex, hopefully we get a Thanksgiving announcement.

With Zimmer addressing their FDA issues and the expiration of the agreement in 2020, do you think that it will be business as usual for an extended period I.e closer to 2020 given the cash on hand? It just seems to be dragging on for so long without any guidance or news.

Good morning. Is the 10Q due by November 15, 2018? That would give us all an indication of the level of outstanding shares / status of conversions.

Thanks

Did anybody get to listen to ZBH's conference call?

The warning letter was issued on August 24, 2018 with Zimmer to respond within 15-business days (~ September 14, 2018). Link below.

https://www.fda.gov/ICECI/EnforcementActions/WarningLetters/ucm618429.htm

The previous letter was issued on April 24, 2018. Given this timeline, are we to expect a response later this year (into next year).

Without any substantial PR, the share price will continue to remain flat / erode.

Hopefully, we get some positive news shortly.

Thanks

We have heard nothing of the status of the Japan approval. Is it possible that they may have received same but have not just issued a PR?

I agree and while no one has a crystal ball to determine timelines, i believe that a sale / merger is close. Hopefully within this quarter.

Any theory of what is holding back Japan approval?

CL101 I am sure I speak for many of the retail bulls when i ask what's your take on the recent developments. Are the timelines further protracted?
I continue to really appreciate the informative posts and discussions by Boston and others.

Folks..This sale is subject to shareholder approval but no meeting has yet been carded. From what I read, they are seeking close by Q3 which in essence is September 2018. How quickly can this shareholder vote come off?

While there are so many connections between Zimmer and Amedica, do you still see a RTM still possible / occuring?

This sale is subject to shareholder approval with closure by the end of Q3. Did I miss something but has a shareholder vote been convened and how much notice must be given for such?

Has anyone heard details of ZBH's investor presentation @ MS

If there is no material event until day 81 which cause the price to spike, could they not convert at this low level with no price adjustment?

Did anyone listen to ZBH conference call? Not seeing the call transcripts just yet.

Good morning..just a question...does anyone have an average > $3.24?

So potentially no merger / bo news until after inspection in July?

Is it mandatory to convert the warrants to shares at the conversion price or can they waive the conversion? More so given the 5% threshold...this will ultimately impact on the number of shares outstanding.

How long after does Nasdaq issue a deficiency notice if no annual meeting is held in June?

Isn't it 40 days after offering? Which should be mid July?